CORRIGENDUM: Interim results of the first stage of a multicenter open multi-cohort study of the safety, pharmacokinetics, pharmacodynamics and efficacy of veranafusp alfa in adult patients with mucopolysaccharidosis type II. [Pharmacy & Pharmacology. 2026;14(1):81-96. DOI: 10.19163/2307-9266-2026-14-1-81-96]

Editorial Edit

For citations:

Edit E. CORRIGENDUM: Interim results of the first stage of a multicenter open multi-cohort study of the safety, pharmacokinetics, pharmacodynamics and efficacy of veranafusp alfa in adult patients with mucopolysaccharidosis type II. [Pharmacy & Pharmacology. 2026;14(1):81-96. DOI: 10.19163/2307-9266-2026-14-1-81-96]. Pharmacy & Pharmacology. 2026;14(2):214. https://doi.org/10.19163/2307-9266-2026-14-2-214

Views PDF (Rus): 66
Views PDF (Eng): 44

JATS XML

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2307-9266 (Print)
ISSN 2413-2241 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Pharmacy & Pharmacology

For citations:

Cookies policy